Valuation: Thermo Fisher Scientific, Inc.

Capitalization 190B 160B 146B 139B 258B 17,178B 268B 1,695B 673B 8,296B 711B 697B 28,994B P/E ratio 2025
32.7x
P/E ratio 2026 * 25.8x
Enterprise value 218B 184B 168B 160B 297B 19,740B 308B 1,948B 773B 9,533B 817B 801B 33,318B EV / Sales 2025
5.55x
EV / Sales 2026 * 4.6x
Free-Float
86.06%
Yield 2025 *
0.33%
Yield 2026 * 0.36%
1 day-0.98%
1 week-7.00%
Current month-12.75%
1 month-18.82%
3 months-12.77%
6 months+4.08%
Current year-12.88%
1 week 493.64
Extreme 493.64
550.95
1 month 493.64
Extreme 493.64
643.99
Current year 493.64
Extreme 493.64
643.99
1 year 385.46
Extreme 385.46
643.99
3 years 385.46
Extreme 385.46
643.99
5 years 385.46
Extreme 385.46
672.34
10 years 126.42
Extreme 126.42
672.34
Manager TitleAgeSince
Chief Executive Officer 58 15/10/2009
Director of Finance/CFO 59 01/08/2015
Chief Tech/Sci/R&D Officer - 01/10/2023
Director TitleAgeSince
Director/Board Member 68 09/11/2006
Chairman 58 26/02/2020
Director/Board Member 65 26/05/2009
Change 5d. change 1-year change 3-years change Capi.($)
-0.98%-7.00%-5.08%-11.66% 190B
+1.51%-0.47%-18.42%+101.52% 173B
-1.10%-1.86%+3.04%-17.04% 150B
+0.82%-2.02%-29.57%+58.06% 111B
+0.79%-1.74%-29.86%-20.76% 53.87B
-0.75%-3.61%-0.42%-0.94% 44.03B
+2.78%-7.02%+8.40%+18.06% 36.79B
+2.15%-0.38%-12.87%+10.65% 36.61B
+0.74%-2.91%-6.58%-17.79% 35.58B
-1.19%-1.96%-25.99%-42.05% 32.52B
Average +0.48%-2.48%-11.74%+7.80% 86.27B
Weighted average by Cap. +0.21%-2.46%-11.40%+19.79%

Financials

2025 2026 *
Net sales 44.28B 37.31B 34.03B 32.49B 60.3B 4,010B 62.66B 396B 157B 1,937B 166B 163B 6,768B 46.82B 39.45B 35.98B 34.35B 63.77B 4,241B 66.25B 419B 166B 2,048B 176B 172B 7,157B
Net income 6.72B 5.67B 5.17B 4.93B 9.16B 609B 9.52B 60.11B 23.86B 294B 25.22B 24.7B 1,028B 7.36B 6.2B 5.66B 5.4B 10.02B 667B 10.41B 65.79B 26.12B 322B 27.6B 27.03B 1,125B
Net Debt 28.29B 23.83B 21.74B 20.75B 38.53B 2,562B 40.03B 253B 100B 1,237B 106B 104B 4,324B 25.48B 21.47B 19.58B 18.7B 34.71B 2,308B 36.06B 228B 90.43B 1,115B 95.56B 93.6B 3,895B
Logo Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (73.2%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - scientific analysis equipments (16.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.; - diagnostics equipment and products (10.1%). Net sales break down by source of revenue between sales of products (58.4%) and services (41.6%). Net sales break down geographically as follows: North America (52.5%), Europe (25.3%), Asia/Pacific (18.6%) and other (3.6%).
Employees
125,000
Date Price Change Volume
13/02/26 504.82 $ -0.98% 3,188,361
12/02/26 509.82 $ -3.29% 4,742,103
11/02/26 527.17 $ -2.34% 3,367,617
10/02/26 539.80 $ -1.27% 2,022,058
09/02/26 546.76 $ +0.72% 2,107,617
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
504.82USD
Average target price
666.46USD
Spread / Average Target
+32.02%

Quarterly revenue - Rate of surprise